TrialScientific reports2024

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.

Charles S Cleeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.